Manufacturing
Pharmaceutical
Biopharmaceutical

Mallinckrodt

$23.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (0.59%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Mallinckrodt and other stocks, options, ETFs, and crypto commission-free!

About

MALLINCKRODT PUBLIC LIMITED COMPANY, also called Mallinckrodt, is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. Read More It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Staines-Upon-Thames, the United Kingdom.

Employees
3,700
Headquarters
Staines-Upon-Thames, Surrey
Founded
2015
Market Cap
1.97B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.60M
High Today
$24.12
Low Today
$23.27
Open Price
$23.44
Volume
659.63K
52 Week High
$36.65
52 Week Low
$11.65

Collections

Manufacturing
Pharmaceutical
Biopharmaceutical
Health
Medical
Technology
2013 IPO

News

Yahoo Finance10h

Mallinckrodt (MNK) Gains But Lags Market: What You Should Know

Mallinckrodt (MNK) closed the most recent trading day at $23.80, moving +0.59% from the previous trading session. This change lagged the S&P 500's 1.09% gain on the day. Elsewhere, the Dow gained 0.84%, while the tech-heavy Nasdaq added 1.42%. Heading into today, shares of the specialty pharmaceutical company had gained 11.5% over the past month, outpacing the Medical sector's gain of 1.58% and the S&P 500's gain of 1.18% in that time. Investors will be hoping for strength from MNK as it approaches its ne...

4
MarketWatchMar 20

Mallinckrodt PLC Stock Quote (U.S.: NYSE)

Shares of drugmaker Mallinckrodt Plc were up 14% Tuesday morning after the British pharmaceutical company reported fourth-quarter earnings and revenue that soundly beat Wall Street expectations.

29
Seeking AlphaMar 18

New finance chief at Mallinckrodt; shares up 3%

Mallinckrodt (MNK +2.7% ) appoints Bryan Reasons as CFO succeeding interim CFO George Kegler who will retire after a transition period.

23

Earnings

$1.10
$1.46
$1.82
$2.18
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 7, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.